Last 12 months
Inside the activity.
12 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 6 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2022 Filed Feb 25, 2022 16:37 UTC |
Hayes Christopher G.Chief Legal Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013202 · doc4.xml · derivative · entry 1 Hayes Christopher G. · CIK 0001805359 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-23 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 24, 2023 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 21:36 UTC |
Goldenberg GaryChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013199 · doc4.xml · derivative · entry 1 Goldenberg Gary · CIK 0001741938 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-23 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 24, 2023 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 21:33 UTC |
Bonaccorso JoeChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013193 · doc4.xml · derivative · entry 1 Bonaccorso Joe · CIK 0001741973 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-23 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 24, 2023 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 21:30 UTC |
White TedDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013191 · doc4.xml · derivative · entry 1 White Ted · CIK 0001741964 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-02-23 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 24, 2023 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 13:20 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 19,977 | $9.22 | $184,187.94 |
DisclosureSEC source: 0001209191-21-068031 · doc4.xml · nonDerivative · entry 2 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,149,394 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.01 to $9.77 inclusive. F4 · balance_after: Consists of 7,754,783 shares of common stock held by Mr. Manning and 394,611 shares of common stock held by Mr. Manning jointly with his spouse. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 13:20 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 30,023 | $9.45 | $283,717.35 |
DisclosureSEC source: 0001209191-21-068031 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,129,417 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.335 to $9.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3). F2 · balance_after: Consists of 7,754,783 shares of common stock held by Mr. Manning and 374,634 shares of common stock held by Mr. Manning jointly with his spouse. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:04 UTC |
Kohler TerryChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0001209191-21-047477 · doc4.xml · derivative · entry 1 Kohler Terry · CIK 0001872285 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2031-07-15 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on July 16, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| July 06, 2021 Filed Feb 15, 2022 02:15 UTC |
Manning Paul BDirector · 10% owner
|
GiftCommon Stock | 739,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009596 · doc5.xml · nonDerivative · entry 2 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,889,224 F2 · ownership.direct: Consists of 7,754,783 shares of common stock held by Mr. Manning and 1,134,441 shares of common stock held by Mr. Manning jointly with his spouse. Read SEC document |
| July 06, 2021 Filed Feb 15, 2022 02:15 UTC |
Manning Paul BDirector · 10% owner
|
GiftCommon Stock | 739,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009596 · doc5.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:55 UTC |
Nguyen DiemDirector
|
GrantStock Option (right to buy) · Derivative | 5,834 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-040264 · doc4.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2031-06-09 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:59 UTC |
Ballaron CraigDirector
|
GrantStock Option (right to buy) · Derivative | 5,834 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-040269 · doc4.xml · derivative · entry 1 Ballaron Craig · CIK 0001779433 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2031-06-09 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:58 UTC |
PRYGOCKI MARK A SRDirector
|
GrantStock Option (right to buy) · Derivative | 5,834 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-040267 · doc4.xml · derivative · entry 1 PRYGOCKI MARK A SR · CIK 0001257544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2031-06-09 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:56 UTC |
Eichenfield LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 5,834 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-040265 · doc4.xml · derivative · entry 1 Eichenfield Lawrence · CIK 0001814892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2031-06-09 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 10, 2021 Filed Jun 17, 2021 20:35 UTC Amendment |
Nguyen DiemDirector
|
GrantStock Option (right to buy) · Derivative | 8,109 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-041447 · doc4a.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,109 Underlying: Common Stock · 8,109 shares Expires 2031-06-09 F1 · shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F1 · balance_after: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. Read SEC document |
| June 10, 2021 Filed Jun 17, 2021 20:36 UTC Amendment |
PRYGOCKI MARK A SRDirector
|
GrantStock Option (right to buy) · Derivative | 8,109 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-041449 · doc4a.xml · derivative · entry 1 PRYGOCKI MARK A SR · CIK 0001257544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,109 Underlying: Common Stock · 8,109 shares Expires 2031-06-09 F1 · shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F1 · balance_after: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. Read SEC document |
| June 10, 2021 Filed Jun 17, 2021 20:33 UTC Amendment |
Ballaron CraigDirector
|
GrantStock Option (right to buy) · Derivative | 8,109 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-041444 · doc4a.xml · derivative · entry 1 Ballaron Craig · CIK 0001779433 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,109 Underlying: Common Stock · 8,109 shares Expires 2031-06-09 F1 · shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F1 · balance_after: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. Read SEC document |
| June 10, 2021 Filed Jun 17, 2021 20:31 UTC Amendment |
Eichenfield LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 8,109 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0001209191-21-041443 · doc4a.xml · derivative · entry 1 Eichenfield Lawrence · CIK 0001814892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,109 Underlying: Common Stock · 8,109 shares Expires 2031-06-09 F1 · shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. F1 · balance_after: The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 08:42 UTC |
Hayes Christopher G.Chief Legal Officer
|
PurchaseCommon Stock | 2,500 | $9.79 | $24,475.00 |
DisclosureSEC source: 0001209191-21-038481 · doc4.xml · nonDerivative · entry 1 Hayes Christopher G. · CIK 0001805359 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.782 to $9.803 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 12:44 UTC |
White TedDirector · President and CEO
|
PurchaseCommon Stock | 4,000 | $9.95 | $39,800.00 |
DisclosureSEC source: 0001209191-21-038482 · doc4.xml · nonDerivative · entry 1 White Ted · CIK 0001741964 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,966 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.80 to $10.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 12:41 UTC |
DAVIS A BRIANChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $9.89 | $49,450.00 |
DisclosureSEC source: 0001209191-21-038480 · doc4.xml · nonDerivative · entry 1 DAVIS A BRIAN · CIK 0001184432 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,900 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.75 to $9.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 13:12 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 739,830 | $14.75 | $10,912,492.50 |
DisclosureSEC source: 0001209191-21-023388 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 739,830 F1 · ownership.nature: The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 17:01 UTC |
Hayes Christopher G.Chief Legal Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $14.32 | $0.00 |
DisclosureSEC source: 0001209191-21-016972 · doc4.xml · derivative · entry 1 Hayes Christopher G. · CIK 0001805359 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-02-28 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 1, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:06 UTC |
White TedDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $14.32 | $0.00 |
DisclosureSEC source: 0001209191-21-017004 · doc4.xml · derivative · entry 1 White Ted · CIK 0001741964 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-28 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 1, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:05 UTC |
DAVIS A BRIANChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $14.32 | $0.00 |
DisclosureSEC source: 0001209191-21-016997 · doc4.xml · derivative · entry 1 DAVIS A BRIAN · CIK 0001184432 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-02-28 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 1, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:03 UTC |
Goldenberg GaryChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $14.32 | $0.00 |
DisclosureSEC source: 0001209191-21-016984 · doc4.xml · derivative · entry 1 Goldenberg Gary · CIK 0001741938 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-02-28 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 1, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:02 UTC |
Bonaccorso JoeChief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $14.32 | $0.00 |
DisclosureSEC source: 0001209191-21-016978 · doc4.xml · derivative · entry 1 Bonaccorso Joe · CIK 0001741973 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-02-28 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 1, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 20:40 UTC |
Ballaron CraigDirector
|
PurchaseCommon Stock | 4,772 | $8.57 | $40,896.04 |
DisclosureSEC source: 0001209191-20-048401 · doc4.xml · nonDerivative · entry 2 Ballaron Craig · CIK 0001779433 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.81 inclusive. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:40 UTC |
Ballaron CraigDirector
|
PurchaseCommon Stock | 5,228 | $9.16 | $47,888.48 |
DisclosureSEC source: 0001209191-20-048401 · doc4.xml · nonDerivative · entry 1 Ballaron Craig · CIK 0001779433 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,228 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.03 to $9.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2). Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 11:44 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 20,000 | $9.09 | $181,800.00 |
DisclosureSEC source: 0001209191-20-047865 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,099,394 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $9.3279 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Consists of 7,754,783 shares of common stock held by Mr. Manning and 344,611 shares of common stock held by Mr. Manning jointly with his spouse. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 12:40 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 10,000 | $8.55 | $85,500.00 |
DisclosureSEC source: 0001209191-20-047409 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,481,719 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.305 to $8.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 12:35 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 6,000 | $6.92 | $41,520.00 |
DisclosureSEC source: 0001209191-20-047100 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,471,719 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.80 to $6.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:39 UTC |
Stalfort John A IIIDirector
|
PurchaseCommon Stock | 15,700 | $6.38 | $100,166.00 |
DisclosureSEC source: 0001209191-20-046963 · doc4.xml · nonDerivative · entry 2 Stalfort Sean · CIK 0001709418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,110 F2 · price: The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $6.08 to $6.65, inclusive. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 13:30 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 50,000 | $6.51 | $325,500.00 |
DisclosureSEC source: 0001209191-20-046880 · doc4.xml · nonDerivative · entry 2 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,465,719 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.10 to $6.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:39 UTC |
Stalfort John A IIIDirector
|
PurchaseCommon Stock | 15,550 | $6.45 | $100,297.50 |
DisclosureSEC source: 0001209191-20-046963 · doc4.xml · nonDerivative · entry 1 Stalfort Sean · CIK 0001709418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,410 F1 · price: The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $6.24 to $6.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2). Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:37 UTC |
White TedDirector · President and CEO
|
PurchaseCommon Stock | 10,661 | $6.28 | $66,951.08 |
DisclosureSEC source: 0001209191-20-046961 · doc4.xml · nonDerivative · entry 1 White Ted · CIK 0001741964 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,966 F1 · price: The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $6.2493 to $6.4086, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:38 UTC |
DAVIS A BRIANChief Financial Officer
|
PurchaseCommon Stock | 7,900 | $6.24 | $49,296.00 |
DisclosureSEC source: 0001209191-20-046962 · doc4.xml · nonDerivative · entry 1 DAVIS A BRIAN · CIK 0001184432 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.19 to $6.27 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 13:30 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 108,500 | $6.41 | $695,485.00 |
DisclosureSEC source: 0001209191-20-046880 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,415,719 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.23 to $6.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB. Read SEC document |
| August 01, 2020 Filed Aug 3, 2020 22:35 UTC |
Goldenberg GaryChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-20-044549 · doc4.xml · derivative · entry 1 Goldenberg Gary · CIK 0001741938 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2030-08-01 F1 · derivative.exercise_date: 25% of shares subject to the option shall vest on August 1, 2021 (the "Initial Vesting Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| August 01, 2020 Filed Aug 3, 2020 22:34 UTC |
Eichenfield LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 17,502 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-20-044548 · doc4.xml · derivative · entry 1 Eichenfield Lawrence · CIK 0001814892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,502 Underlying: Common Stock · 17,502 shares Expires 2030-07-31 F1 · derivative.exercise_date: 1/3rd of the total shares subject to the option shall vest on August 1, 2021 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:50 UTC |
Ballaron CraigDirector
|
GrantOption Grant (right to buy) · Derivative | 5,834 | $0.00 Strike: $11.38 | $0.00 |
DisclosureSEC source: 0001209191-20-036321 · doc4.xml · derivative · entry 1 Ballaron Craig · CIK 0001779433 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2030-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 11, 2020 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 21:03 UTC |
Goldenberg GaryDirector
|
GrantOption Grant (right to buy) · Derivative | 5,834 | $0.00 Strike: $11.38 | $0.00 |
DisclosureSEC source: 0001209191-20-036345 · doc4.xml · derivative · entry 1 Goldenberg Gary · CIK 0001741938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2030-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 11, 2020 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:49 UTC |
PRYGOCKI MARK A SRDirector
|
GrantOption Grant (right to buy) · Derivative | 5,834 | $0.00 Strike: $11.38 | $0.00 |
DisclosureSEC source: 0001209191-20-036318 · doc4.xml · derivative · entry 1 PRYGOCKI MARK A SR · CIK 0001257544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2030-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 11, 2020 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:11 UTC |
Nguyen DiemDirector
|
GrantStock Option (right to buy) · Derivative | 17,502 | $0.00 Strike: $12.64 | $0.00 |
DisclosureSEC source: 0001209191-20-035997 · doc4.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,502 Underlying: Common Stock · 17,502 shares Expires 2030-06-08 F1 · derivative.exercise_date: 1/3rd of the total shares subject to the option shall vest on June 9, 2021 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:46 UTC |
White TedDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001209191-20-014686 · doc4.xml · derivative · entry 1 White Ted · CIK 0001741964 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-02-26 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 27, 2021 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:46 UTC |
DAVIS A BRIANChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001209191-20-014683 · doc4.xml · derivative · entry 1 DAVIS A BRIAN · CIK 0001184432 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-02-26 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 27, 2021 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:45 UTC |
Burnett PatrickChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001209191-20-014682 · doc4.xml · derivative · entry 1 Burnett Patrick · CIK 0001741987 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-02-26 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 27, 2021 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:44 UTC |
Bonaccorso JoeChief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001209191-20-014679 · doc4.xml · derivative · entry 1 Bonaccorso Joe · CIK 0001741973 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-02-26 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 27, 2021 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 27, 2020 Filed Mar 3, 2020 18:19 UTC |
Hayes Christopher G.General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001209191-20-015606 · doc4.xml · derivative · entry 1 Hayes Christopher G. · CIK 0001805359 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-02-26 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on February 27, 2021 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| October 18, 2019 Filed Oct 21, 2019 20:49 UTC |
DAVIS A BRIANChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $14.65 | $0.00 |
DisclosureSEC source: 0001209191-19-053716 · doc4.xml · derivative · entry 1 DAVIS A BRIAN · CIK 0001184432 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-10-18 F1 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on October 18, 2020 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| October 10, 2019 Filed Oct 10, 2019 21:03 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 6,900 | $15.05 | $103,845.00 |
DisclosureSEC source: 0001209191-19-052936 · doc4.xml · nonDerivative · entry 3 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,079,394 F5 · price: The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $14.74 to $15.175, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F6 · balance_after: Consists of 7,754,783 shares of common stock held by Mr. Manning and 324,611 shares of common stock held by Mr. Manning jointly with his spouse. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.